Endeavor

Combination Therapy Before Surgery Shows Promise for Aggressive Skin Cancer

Moffitt-led study explores how pairing lenvatinib and pembrolizumab strengthens immune response against Merkel cell carcinoma

Immunotherapy Combo Shows Promise as Pre-Surgical Treatment for Merkel Cell Carcinoma

More than half of patients had no detectable tumor cells after treatment with pembrolizumab and lenvatinib

Personalized Vaccine Shows Promise in Merkel Cell Carcinoma

More than half of patients responded to checkpoint inhibitor rechallenge following treatment with vaccine containing streptococcus bacterial antigen

Jimmy Buffett Dies of Rare Skin Cancer

Merkel cell carcinoma linked to sun exposure, weak immune system, older age

World-Renowned Trumpeter Finds Hope in Merkel Cell Carcinoma Clinical Trial

Vince DiMartino has had a robust response rate to the combination treatment of two immunotherapy drugs

Terry Bradshaw Tackles Two Cancers Over the Past Year

The NFL Hall of Fame quarterback said he was treated for Merkel cell carcinoma and bladder cancer

Merkel Cell Carcinoma: Rare, Deadly and on the Rise

Merkel cell carcinoma is a rare but deadly type of skin cancer that is on the rise, driven by an aging population.